Author： Kan Lixin
Publisher： Humana Press, Inc
ISSN： 1534-8644
Source： Clinical Review in Bone and Mineral Metabolism, Vol.3, Iss.3-4, 2005-09, pp. : 235-237
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disorder characterized by congenital malformation of the great toes and by progressive, postnatal beterotopic bone formation. Although the genetic defect in FOP is not known, several lines of evidence suggest that dysregulation of bone morphogenetic protein (BMP) 4 may be involved in the pathophysiology of the condition. Transgenic mice that overex press BMP4 under the control of the neuron-specific enolase (Nse) promoter is the first mouse model to develop progressive, postnatal heterotopic endochondral ossification. The Nse-BMP4 transgenic mouse provides a unique opportunity to study the pathophysiology and treatment of progressive heterotopic ossification in an animal model relevant to the study of FOP.
Related content
Access to resources
Recommend
By Billings Paul Wu Yangguan Caron Robert Peña Lourdes Young Blanche Pacifici Maurizio Glaser David Shore Eileen Kaplan Frederick
Clinical Review in Bone and Mineral Metabolism, Vol. 3, Iss. 3-4, 2005-09 ,pp. :
The phenotype of fibrodysplasia ossificans progressiva
By Kaplan Frederick Glaser David Shore Eileen Deirmengian Gregory Gupta Rishi Delai Patricia Morhart Rolf Smith Roger Merrer Martine Rogers John Connor J. Kitterman Joseph
Clinical Review in Bone and Mineral Metabolism, Vol. 3, Iss. 3-4, 2005-09 ,pp. :